Rani Therapeutics Holdings Management
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Talat Imran (41 yo)
Mr. Talat Imran has served as Chief Executive Officer and Director of Rani Therapeutics Holdings, Inc. since June 2021 and served as its Vice President of Strategy from January 2014 to June 2021. Mr. Imran...
CEO Compensation Analysis
Compensation vs Market: Talat's total compensation ($USD12.07M) is above average for companies of similar size in the US market ($USD2.78M).
Compensation vs Earnings: Insufficient data to compare Talat's compensation with company performance.
Experienced Management: RANI's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Experienced Board: RANI's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.